FEBUXOSTAT NORMON 120 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Febuxostat Normon 120 mg film-coated tablets EFG

febuxostat

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

1. What is Febuxostat Normon and what is it used for
2. What you need to know before you take Febuxostat Normon
3. How to take Febuxostat Normon
4. Possible side effects
5. Storing Febuxostat Normon
6. Contents of the pack and other information

1. What is Febuxostat Normon and what is it used for

Febuxostat contains the active substance febuxostat and is used to treat gout, which is associated with an excess in the body of a chemical compound called uric acid (urate). In some people, uric acid builds up in the blood to the point where it cannot be dissolved. When this happens, urate crystals form both inside and around the joints and kidneys. These crystals can cause sudden and severe pain, redness, heat, and swelling in the joints (this is called a gout attack). If left untreated, large deposits called tophi can form around the joints and inside them. Tophi can damage the joints and bones.

Febuxostat works by reducing the concentration of uric acid. Keeping the uric acid concentration low by taking febuxostat once a day prevents the formation of crystals and, over time, reduces the symptoms. If the uric acid concentration is kept low for a long enough time, the size of the tophi is also reduced.

Febuxostat 120 mg film-coated tablets are also used in the treatment and prevention of high levels of uric acid in the blood, which can occur when chemotherapy is started for the treatment of blood cell cancer.

When chemotherapy is administered, cancer cells are destroyed, and as a result, blood uric acid levels increase, unless their formation is prevented.

Febuxostat is for adults.

2. What you need to know before you take Febuxostat Normon

Do not take Febuxostat:

• If you are allergic to febuxostat or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Febuxostat Normon:

• If you have or have had heart failure, heart problems, or stroke.
• If you have or have had kidney disease and/or severe allergic reactions to allopurinol (a medicine used to treat gout).
• If you have or have had liver disease or liver function disorders.
• If you are being treated for high uric acid levels due to Lesch-Nyhan syndrome (a rare inherited disease in which there is too much uric acid in the blood).
• If you have thyroid problems.

If you suffer from allergic reactions to febuxostat, stop taking this medicine (see also section 4).

Possible symptoms of allergic reactions could be:

• Rash including severe forms (e.g., blisters, nodules, exfoliative rash that itches), itching.
• Swelling of the limbs or face.
• Difficulty breathing.
• Fever with swollen lymph nodes.
• Also, life-threatening allergic reactions associated with cardiac arrest.

Your doctor may decide to permanently discontinue treatment with febuxostat.

Rare cases of skin rashes that can be life-threatening (Stevens-Johnson syndrome) have been reported with the use of febuxostat, initially appearing on the trunk as reddish spots in the shape of a target or circular spots that often have a blister in the center. It can also include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (red and swollen eyes). The rash can evolve into generalized blisters or skin peeling.

If you have developed Stevens-Johnson syndrome with the use of febuxostat, you should not restart treatment at any time. If you develop a rash or these skin symptoms, go immediately to the doctor and tell them that you are taking this medicine.

If you suffer from a gout attack (severe pain that starts suddenly accompanied by sensitivity, redness, heat, and swelling of a joint), wait for the attack to subside before starting treatment with febuxostat.

Some people may suffer from a gout attack when starting to take certain medications that control uric acid levels. Not everyone suffers from these attacks, but they can occur even while taking febuxostat, especially during the first weeks or months of treatment. It is essential to continue taking febuxostat even if you suffer from a gout attack, as this medicine continues to work to reduce uric acid. If you continue to take febuxostat daily, gout attacks will become less frequent and less painful.

If necessary, your doctor will prescribe other medications to prevent or treat the symptoms of attacks (such as pain and joint swelling).

In patients with very high levels of urates (e.g., those undergoing chemotherapy for cancer), treatment with medications to decrease uric acid may produce the accumulation of xanthine in the urinary tract, with the possible formation of stones, although this has not been observed in patients treated with febuxostat for Tumor Lysis Syndrome.

Your doctor may perform blood tests to check that the liver is working normally.

Children and adolescents

Do not give this medicine to children under 18 years of age, as the safety and efficacy have not been established.

Using Febuxostat Normon with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.

It is especially important that you inform your doctor or pharmacist if you are using medicines that contain any of the following substances, as they may interact with febuxostat, and your doctor may need to take special measures:

• Mercaptopurine (used to treat cancer)
• Azathioprine (used to reduce the immune response)
• Theophylline (used to treat asthma)

Pregnancy and breastfeeding

It is not known if febuxostat can harm the fetus. Febuxostat should not be used during pregnancy. It is not known if febuxostat passes into breast milk. Do not use febuxostat if you are breastfeeding or planning to breastfeed.

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Be aware that you may experience dizziness, drowsiness, blurred vision, and numbness or tingling during treatment, so if this happens, do not drive or operate machinery.

Febuxostat Normon contains lactose

Febuxostat Normon film-coated tablets contain lactose (a type of sugar). If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Febuxostat Normon contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially "sodium-free".

3. How to take Febuxostat Normon

Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

• The recommended dose is one tablet per day. The blister pack has the days of the week printed on the back to help you check that you take your dose every day.
• The tablets are taken orally, with or without food.

Gout

Febuxostat is marketed in 80 mg and 120 mg film-coated tablets. Your doctor will prescribe the most suitable dose for you.

Continue taking Febuxostat every day, even if you no longer have a gout attack.

Prevention and treatment of high levels of uric acid in patients undergoing chemotherapy for cancer

Febuxostat is available in 120 mg tablets.

Start taking febuxostat two days before chemotherapy and continue using it as indicated by your doctor. In general, treatment is short-term.

If you take more Febuxostat than you should

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.

If you forget to take Febuxostat

If you forget a dose of febuxostat, take it as soon as you remember, unless it is almost time to take the next dose; in this case, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for missed doses.

If you stop taking Febuxostat

Even if you feel better, do not stop taking febuxostat unless your doctor tells you to. If you stop taking febuxostat, uric acid levels may increase again, and symptoms may worsen due to the formation of new urate crystals in the joints and kidneys.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and contact your doctor immediately or go to the nearest hospital if you experience any of the following rare side effects (may affect up to 1 in 1,000 people), as you may experience a severe allergic reaction:

• Anaphylactic reactions, hypersensitivity to the medicine (see also section 2 "Warnings and precautions").
• Skin rashes that can be life-threatening, characterized by blistering and peeling of the skin and mucous membranes (e.g., mouth and genitals), painful ulcers in the mouth and/or genital areas, accompanied by fever, sore throat, and fatigue (Stevens-Johnson syndrome/toxic epidermal necrolysis), or by swollen lymph nodes, liver enlargement, hepatitis (including liver failure), increased white blood cell count (leukocytosis, with or without eosinophilia) (see section 2).
• Generalized skin rashes.

Common side effects(may affect up to 1 in 10 people) are:

• Abnormal liver test results.
• Diarrhea.
• Headache.
• Rash (including various types of rash, see below "uncommon" and "rare" sections).
• Nausea.
• Increased gout symptoms.
• Localized swelling due to fluid retention in tissues (edema).
• Dizziness.
• Breathing difficulties.
• Itching.
• Pain in the limbs, muscle/joint pain.
• Fatigue.

Other side effects not mentioned above are included below.

Uncommon side effects(may affect up to 1 in 100 people) are:

• Decreased appetite, change in blood sugar levels (diabetes) whose symptom may be excessive thirst, increased blood fats, weight gain.
• Decreased sex drive.
• Difficulty sleeping, drowsiness.
• Numbness, tingling, decreased or altered sensitivity (hypoesthesia, hemiparesis, or paresthesia), altered sense of taste, decreased sense of smell (hyposmia).
• Abnormalities in the ECG (electrocardiogram), irregular or rapid heartbeat, perception of heartbeats (palpitations).
• Hot flashes or flushing (redness of the face or neck), increased blood pressure, bleeding (hemorrhage, observed only in patients receiving chemotherapy for blood diseases).
• Cough, discomfort or chest pain, inflammation of the nasal passages and/or throat (upper respiratory tract infection), bronchitis, lower respiratory tract infection.
• Dry mouth, abdominal pain or discomfort, gas, upper abdominal pain, heartburn or indigestion, constipation, more frequent bowel movements, vomiting, stomach upset.
• Itchy rash, hives, skin inflammation or discoloration, small red or purple spots on the skin, small bumps on the skin, bumps on the skin covered with small interconnected bumps, rash, bumps, and spots on the skin, increased sweating, night sweats, hair loss, skin redness (erythema), psoriasis, eczema, other skin disorders.
• Muscle cramps, muscle weakness, bursitis or arthritis (inflammation of the joints, usually accompanied by pain, swelling, or stiffness), back pain, muscle spasms, muscle stiffness and/or joint stiffness.
• Blood in urine, abnormally frequent urination, abnormal urine tests (increased protein concentration in urine), reduced kidney function, urinary tract infection.
• Chest pain, chest discomfort.
• Gallstones or bile duct stones (cholelithiasis).
• Increased levels of thyroid-stimulating hormone (TSH) in blood.
• Changes or decrease in urine volume due to kidney inflammation (tubulointerstitial nephritis).
• Liver inflammation (hepatitis).
• Yellowing of the skin (jaundice).
• Bladder infection.
• Liver damage.
• Increased levels of creatine phosphokinase in blood (an indicator of muscle damage).
• Sudden cardiac death.
• Low red blood cell count (anemia).
• Depression.
• Sleep disorder.
• Loss of taste.
• Burning sensation.
• Dizziness.
• Circulatory failure.
• Lung infection (pneumonia).
• Mouth sores; mouth inflammation.
• Gastrointestinal perforation.
• Rotator cuff syndrome.
• Polymyalgia rheumatica.
• Feeling of heat.
• Sudden loss of vision due to blockage of an eye artery.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Febuxostat Normon

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Place the empty packaging and any unused medicinal product in the SIGRE collection point at the pharmacy. If you have any further questions on the disposal of unused medicinal products, ask your pharmacist. This will help protect the environment.

6. Packaging Content and Additional Information

Composition of Febuxostat Normon

The active ingredient is febuxostat.

Febuxostat Normon 120 mg film-coated tablets EFG: Each tablet contains 120 mg of febuxostat.

The other components are:

Tablet core:Lactose monohydrate, microcrystalline cellulose, magnesium stearate, hydroxypropylcellulose, sodium croscarmellose, anhydrous lactose, colloidal anhydrous silica, sodium lauryl sulfate.

Tablet coating:Poly(vinyl alcohol) (E1203), titanium dioxide (E171), macrogol 3350 (E1521), talc (E553b), yellow iron oxide (E172)

Appearance of the Product and Packaging Content

Febuxostat Normon 120 mg film-coated tablets EFG: Film-coated, biconvex tablets, pale yellow to yellow in color, oblong, engraved in relief with "120" on one side and smooth on the other.

Febuxostat Normon 120 mg film-coated tablets EFG: Packaged in PVC/PCTFE/Aluminum or PVC/PE/PVDC/Aluminum blisters.

Febuxostat Normon 120 mg film-coated tablets EFG: Marketed in packages of 14, 28, 42, 56, 84, and 98 film-coated tablets.

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

LABORATORIOS NORMON, S.A.

Ronda de Valdecarrizo, 6. 28760 Tres Cantos, Madrid (Spain)

Manufacturer:

Genepharm S.A.

18 km Marathonos Avenue,

153 51 Pallini Attiki

Greece

Or

LABORATORIOS NORMON, S.A.

Ronda de Valdecarrizo, 6. 28760 Tres Cantos, Madrid (Spain)

Date of the Last Revision of this Leaflet:January 2025

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/